Fingerprint
Dive into the research topics of 'Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis
Gil Yosipovitch, Marjolein de Bruin-Weller, April Armstrong, Jashin J Wu, Pedro Herranz, Diamant Thaçi, Dimittri Delevry, Gaëlle Bégo-Le Bagousse, Raymond Zhang, Brad Shumel, Ana B Rossi, Jingdong Chao
- Department of Dermatology and Itch Center
- University of Miami
- National Expertise Center of Atopic Dermatitis
- Department of Dermatology and Allergology
- Utrecht University
- Department of Dermatology
- Keck School of Medicine of USC
- University of Southern California
- Dermatology Research and Education Foundation
- UC Irvine
- University Hospital of La Paz (IdiPaz)
- Regeneron Pharmaceuticals, Inc.
- Tarrytown
- Sanofi
- Chilly Mazarin
- AstraZeneca France, Rueil Malmaison, France.
- Sanofi Genzyme
- Illumina Cambridge